Phase II Trial of Cetuximab, Irinotecan, Cisplatin (CPC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Cisplatin; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 10 Nov 2014 Biomarkers information updated
- 03 Dec 2012 Planned end date changed from 1 Nov 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 30 Aug 2010 Planned end date changed from 1 Nov 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.